TCL Archive Medicare to cut payments for cancer drugs by 2-8%. ASCO estimates total cut in reimbursement at $500 million. July 30, 2004
TCL Archive In Brief: Megastrol Acetate Still Under FDA Review; Mays Hired For NCI’s Technology Office July 20, 1990
